Source-grounded facts extracted from Nordicus Partners Corp's SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Andrew J. Ritter resigned as Director at Nordicus Partners Corp.
“On July 7, 2026, Andrew J. Ritter resigned from the Board of Directors of Nordicus Partners Corporation (the “Company”), effective immediately, to pursue other time-consuming business opportunities.”
Nordicus Partners Corp issued 131,000 restricted shares of our common stock of common stock to ten private investors for $2.75 per share.
“In December 2025, we issued to ten private investors a total of 131,000 restricted shares of our common stock, par value $0.01 per share. The price per share was $2.75.”
Nordicus Partners Corp entered into a equity purchase with ten private investors valued at $2.75 per share.
“In December 2025, we issued to ten private investors a total of 131,000 restricted shares of our common stock, par value $0.01 per share. The price per share was $2.75.”
Nordicus Partners Corp entered into a equity purchase with eight private investors valued at 416,000 restricted shares, $2.75 per share (effective 2025-12-05).
“In October through December 2025, we issued to eight private investors a total of 416,000 restricted shares of our common stock, par value $0.01 per share. The price per share was $2.75. On December 5, 2025, we determined to close the private offering of such shares on these terms.”
Nordicus Partners Corp issued 416,000 shares of common stock to eight private investors for $2.75 per share.
“in October through December 2025, we issued to eight private investors a total of 416,000 restricted shares of our common stock at a purchase price of $2.75 per share.”
Nordicus Partners Corp issued 1,057,500 restricted shares of common stock to 54 private investors for $1.90 per share.
“in July through September 2025, we issued to 54 private investors a total of 1,057,500 restricted shares of our common stock at a purchase price of $1.90 per share.”
Nordicus Partners Corp completed an acquisition involving shareholders of Bio-Convert ApS for issued 12,000,000 restricted shares of its common stock (closed 2024-11-12).
“shares of the capital stock of Bio-Convert (the “Bio-Convert Shares”), representing 100% of Bio-Convert’s outstanding shares of capital stock. In exchange, the Company issued 12,000,000 restricted shares of its common stock (the “Company Shares”) to the Sellers. The transaction was consummated on November 12, 2024. A copy of the Agreement is attached to this”
Nordicus Partners Corp completed an acquisition involving shareholders of Orocidin A/S (closed 2024-11-12).
“on November 12, 2024, the Company acquired the Orocidin Shares pursuant to the Agreement.”
Peter Severin was appointed as Chairman of the Board of Directors at Nordicus Partners Corp.
“and the remaining Board members appointed Peter Severin as his replacement and as Chairman of the Board of Directors.”
Christian Hill-Madsen resigned as Director at Nordicus Partners Corp.
“Effective June 3, 2024, Christian Hill-Madsen resigned from the Board of Directors of Nordicus Partners Corporation (the “Company”), and the remaining Board members appointed Peter Severin as his replacement and as Chairman of the Board of Directors.”
Nordicus Partners Corp completed an acquisition involving certain shareholders of Orocidin A/S (closed 2024-05-13).
“the Company acquired the Orocidin Shares pursuant to the Agreement.”
Nordicus Partners Corp entered into Stock Purchase and Sale Agreement with certain shareholders of Orocidin A/S (effective 2024-05-13).
“On May 13, 2024, Nordicus Partners Corporation (the “Company”) and certain shareholders (the “Sellers”) of Orocidin A/S, a Danish stock corporation (“Orocidin”) entered into a Stock Purchase and Sale Agreement (the “Agreement”), under which the Sellers sold to the Company 525,597 shares of the capital stock of Orocidin (the “Orocidin Shares”), representing 95.0% of Orocidin’s outstanding shares of capital stock.”
Nordicus Partners Corp completed an acquisition involving GK Partners ApS for 2,500,000 restricted shares of its common stock (closed 2023-06-20).
“(the “Agreement”), under which the Seller sold to the Company 5,000,000 restricted shares of common stock of Myson, Inc. (the “Myson Shares”). In exchange, the Company issued 2,500,000 restricted shares of its common stock (the “Company Shares”) to the Seller. The transaction was consummated on June 20, 2023. A copy of the Agreement is attached to this Report on”
Nordicus Partners Corp entered into Agreement with GK Partners ApS (effective 2023-06-20).
“On June 20, 2023, Nordicus Partners Corporation (the "Company") and GK Partners ApS (the "Seller") entered into a Stock Purchase and Sale Agreement (the "Agreement"), under which the Seller sold to the Company 5,000,000 restricted shares of common stock of Myson, Inc. (the "Myson Shares").”
Henrik Keller was appointed as director at Nordicus Partners Corp.
“On June 9, 2023, Tom Glasesner Larsen resigned from the Company’s board of directors, and the remaining board members appointed Henrik Keller as his replacement.”
Tom Glasesner Larsen resigned as director at Nordicus Partners Corp.
“On June 9, 2023, Tom Glasesner Larsen resigned from the Company’s board of directors, and the remaining board members appointed Henrik Keller as his replacement.”
Nordicus Partners Corp engaged Fruci & Associates II, PLLC as its auditor.
“approved the engagement of Fruci & Associates II, PLLC ("Fruci & Associates ") to serve as the Company's independent registered public accounting firm”
Nordicus Partners Corp dismissed BF Borgers CPA PC as its auditor.
“terminated BF Borgers CPA PC ("BFB") as the independent registered public accounting firm for the Company”
Nordicus Partners Corp: Name change from EKIMAS Corporation to Nordicus Partners Corporation (effective 2023-05-13).
“On May 13, 2023, the Delaware Secretary of State accepted for filing an amendment to the registrant’s certificate of incorporation changing its name from EKIMAS Corporation to Nordicus Partners Corporation.”
Nordicus Partners Corp: Company is no longer considered a shell company after the Business Combination.
“Following the transactions described above, the Company is no longer considered a shell company, as that term is defined in Rule 12b-2 under the Exchange Act.”
Nordicus Partners Corp completed an acquisition involving GK Partners ApS, Henrik Rouf, Life Science Power House ApS for 2,500,000 shares of Purchaser Common Stock.
“assigned and conveyed to the Company all right, title and interest in and to all of the issued and outstanding shares of capital stock of Nordicus for an aggregate of 2,500,000 shares of Purchaser Common Stock. As a result of the Business Combination, Nordicus became a 100% wholly owned subsidiary of the Company. The Purchaser Common Stock being issued”
Bennett J. Yankowitz was appointed as chief executive officer and sole director at Nordicus Partners Corp.
“Bennett J. Yankowitz was appointed as the Company's chief executive officer and sole director.”
Michael F. Adams resigned as chief executive officer and sole director at Nordicus Partners Corp.
“Michael F. Adams resigned as the chief executive officer and sole director of the Company”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.